Cough medicine ingredient could prove effective in prostate cancer treatmentDecember 20th, 2008 - 12:44 pm ICT by ANI
Washington, Dec 20 (ANI): An ingredient present in a common cough suppressant has been found to be effective in the treatment of advanced prostate cancer, according to a new study.
The collaborative study revealed that noscapine, which has been used in cough medication for nearly 50 years, reduced tumour growth in mice by 60 percent and limited the spread of tumours by 65 percent without causing harmful side effects.
While prostate cancer is slow growing in most men, it is considered advanced when it spreads beyond the prostate. There is no known cure.
The laboratory study was a joint effort by Dr. Israel Barken of the Prostate Cancer Research and Educational Foundation, Moshe Rogosnitzky of MedInsight Research Institute, and Dr. Jack Geller of The University of California San Diego.
Noscapine has previously been studied as a treatment for breast, ovarian, colon, lung and brain cancer and for various lymphomas, chronic lymphocytic leukemia and melanoma. However, this is the first study to demonstrate its effectiveness in treating prostate cancer.
Noscapine is a naturally-occurring substance, a non-addictive derivative of opium. As a natural substance, noscapine cannot be patented, which has limited the potential for clinical trials.
Since noscapine is approved for use in many countries as a cough suppressant, however, it is available to doctors to prescribe for other uses as well. This common practice is known as “off-label” prescription. Noscapine is increasingly being used off-label to treat a variety of cancers.
Barken used noscapine to treat a handful of prostate cancer patients before retiring from clinical practice.
Barken is encouraging academic institutions to follow up this successful laboratory research with a human clinical trial.
Rogosnitzky pointed out the significant advantages that noscapine could present as a treatment for prostate cancer.
“Noscapine is effective without the unpleasant side effects associated with other common prostate cancer treatments. Because noscapine has been used as a cough-suppressant for nearly half a century, it already has an extensive safety record. This pre-clinical study shows that the dose used to effectively treat prostate cancer in the animal model was also safe, he said.
Currently, hormone therapy and chemotherapy, along with radiation and surgery, are used to slow the progression of advanced prostate cancer. Side effects resulting from these treatments include impotence, incontinence, fatigue, anemia, brittle bones, hair loss, reduced appetite, nausea and diarrhea.
However, no toxic side effects were observed in the laboratory study of noscapine.
The study was published in the latest issue of the European medical journal Anticancer Research. (ANI)
- Common cough medicine ingredient can treat prostate cancer - Dec 20, 2008
- Hormone therapy 'doubles survival chances in men with prostate cancer' - Mar 25, 2011
- Oregano can help protect against prostate cancer - Apr 25, 2012
- Beehive extract may arrest prostate cancer - May 06, 2012
- Asian mushrooms could help fight prostate cancer - May 24, 2011
- Potent anticancer drug isolated from weed - Jul 10, 2012
- Magnets help fight prostate cancer - Nov 09, 2011
- Protein that protects against prostate cancer discovered - Feb 01, 2011
- Scientists find new way to 'starve' cancer cells - Apr 05, 2011
- New procedure busts deadly brain tumour cells - Feb 06, 2012
- Cholesterol drug could treat prostate cancer - Sep 21, 2010
- Australian scientists identify new way to treat prostate cancer - Feb 26, 2010
- High level of testosterone may speed up prostate cancer - Jul 31, 2012
- New drugs to kill cancers minus side-effects - May 21, 2012
- Electric shocks soften up cancer cells for treatment - Dec 07, 2010
Tags: academic institutions, brain cancer, california san diego, chronic lymphocytic leukemia, collaborative study, cough medication, cough medicine ingredient, cough suppressant, dr jack, israel barken, jack geller, laboratory research, laboratory study, natural substance, noscapine, prostate cancer, prostate cancer patients, prostate cancer research, prostate cancer treatment, university of california san diego